{"name":"Repromed","slug":"repromed","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Menevit anti-oxidant","genericName":"Menevit anti-oxidant","slug":"menevit-anti-oxidant","indication":"Male infertility associated with oxidative stress","status":"phase_3"}]}],"pipeline":[{"name":"Menevit anti-oxidant","genericName":"Menevit anti-oxidant","slug":"menevit-anti-oxidant","phase":"phase_3","mechanism":"Menevit is an oral antioxidant supplement containing coenzyme Q10, L-carnitine, vitamin E, vitamin C, zinc, folate, and garlic extract designed to improve male fertility by reducing oxidative stress in sperm.","indications":["Male infertility associated with oxidative stress"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQSFBPQ3NxTzJvT0tZS21oUWtXMjV3eWI4UjlfckZaY3ZYY2ZORHhoVWhRWHJnZXlKSkdGa012NmZKQ2N0SWNoUTlZeEx3SzJod2FzQmhqSkdkQVpLS2ZNM3BlWTBwVlZxalp4MzlkSWs0dktZMTEzRjMzZ0pOaVlCZzVlajBZN1l1RTM4RUR1OXFsNHE3aXZXZWZub3hncW4xS1NSMGZUSEMxQUNhcmhmQ0EzNlhNNEJ3OEQ4OVNFQUVwc3lhb0dQX21sUjNfSE1wUC1mSXN6QkJ5SUFvOVhfN0hJOUtxeFQwZW9GdW9RaF9ielpaV0R4UkhmcF9CSXd1UEpLUk50eFQ2RWttZlR3?oc=5","date":"2026-03-13","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPdlpvVEk4VUxxYkhjMnVVSExfZE95MloyZHQ5NmFjd2NjQUhZUV9qX05Da2U1THZLcmJiTmhhSXVPVWFoYTktRHBWZldpVDJUalEzSUVfdWtfT2xkU0hNZ1QyU21QRDJrUWJYNGllRks3S29vM1kwZHBXbjI3QnFIdS12bjNjQWQ0YUdKdTQyeEZ2aE03dnRab2ItcTlkU21kdWozcExqLVBmNVl6VFNDUHI1Z1lDVFJqT3JZbS04WFd5ZUM4eEFFazJFUzl0S2JQSzdQcEhiR2tZNWNmNjVNNXFtbWJSOVE4NFBnUG5aSnBtbl9GMFNDQV9KMXFXXzNXS0J0VUpZaw?oc=5","date":"2026-03-10","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on Top Healthcare Stocks: MBX Biosciences, Inc. (MBX), REPRO-MED Systems (KRMD) - The Globe and Mail","headline":"Analysts Are Bullish on Top Healthcare Stocks: MBX Biosciences, Inc. (MBX), REPRO-MED Systems (KRMD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOWW42Z3NobXRZSWNaWXZCNXZQVkZDVDZ2WEd6NWlYdjRtQ3d3azlNcktYUlhoSXlXbVU2T3F5THFEX1ZmNnd0SHNJaFhNbzhxc29uWkVDcC1ibWx6WFlJX0NpZHNpbGphSEhUbVNQRmNlZnFWZTBvN21YOTdFRzhNWlllOTVfOV9rbmVHeVJLcy1tUW9UaEhKbTFZSnlmSXk3NHBIMVU4aklPLXdBY0JvWUtzVGRvVUE5?oc=5","date":"2013-11-27","type":"pipeline","source":"The Irish Times","summary":"Inside Track Q&A: Declan Keane, director of ReproMed clinic - The Irish Times","headline":"Inside Track Q&A: Declan Keane, director of ReproMed clinic","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}